Use of CCL7 antagonist or inhibitor in treating renal disease or condition

TW202631186APending Publication Date: 2026-08-01TAO YUAN GENERAL HOSPITAL MINIST OF HEALTH & WELFARE +2
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
TAO YUAN GENERAL HOSPITAL MINIST OF HEALTH & WELFARE
Filing Date
2025-01-16
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001069509_001
    Figure TWG2TA001069509_001
  • Figure TWG2TA001069509_002
    Figure TWG2TA001069509_002
  • Figure TWG2TA001069509_003
    Figure TWG2TA001069509_003
Patent Text Reader

Abstract

Provided is a use of CCL7 antagonist or inhibitor for manufacture of a pharmaceutical composition for treating or preventing a renal disease or condition.
Need to check novelty before this filing date? Find Prior Art